Literature DB >> 15063598

Mechanism of intestinal entry of infectious prion protein in the pathogenesis of variant Creutzfeldt-Jakob disease.

Subrata Ghosh1.   

Abstract

The pathogenesis of variant Creutzfeldt-Jakob disease (vCJD) is most likely to be dependent on intestinal entry of orally ingested infectious prion proteins, though tonsils or other oral portals of entry are possible. The exact route of entry of infectious prion proteins is uncertain but receptors for prion proteins such as laminin receptor precursor (LRP) may be expressed on intestinal brush border. Cellular prion protein (PrP(c)) is expressed on intestinal enteric nervous system and is separated by a single layer of epithelial cells from ingested infectious prion proteins. Intestinal M cells in the Peyer's patches may also transcytose prion proteins which may be transported to the lymphatic system by migrating dendritic cells underlying the M cells. The relative importance of the several potential portals of intestinal entry of infectious prion proteins is uncertain but may determine susceptibility of the population and also potential preventive strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063598     DOI: 10.1016/j.addr.2003.10.035

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  10 in total

Review 1.  The bowel and beyond: the enteric nervous system in neurological disorders.

Authors:  Meenakshi Rao; Michael D Gershon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-20       Impact factor: 46.802

Review 2.  Prion diseases and the gastrointestinal tract.

Authors:  G A Davies; Adam R Bryant; John D Reynolds; Frank R Jirik; Keith A Sharkey
Journal:  Can J Gastroenterol       Date:  2006-01       Impact factor: 3.522

3.  Oral scrapie infection modifies the homeostasis of Peyer's patches' dendritic cells.

Authors:  Gauthier Dorban; Valérie Defaweux; Etienne Levavasseur; Caroline Demonceau; Olivier Thellin; Sylvain Flandroy; Joëlle Piret; Nandini Falisse; Ernst Heinen; Nadine Antoine
Journal:  Histochem Cell Biol       Date:  2007-07-11       Impact factor: 4.304

4.  Alimentary prion infections: Touchdown in the intestine.

Authors:  Bianca Da Costa Dias; Katarina Jovanovic; Stefan F T Weiss
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

5.  Iron content of ferritin modulates its uptake by intestinal epithelium: implications for co-transport of prions.

Authors:  Solomon Raju Bhupanapadu Sunkesula; Xiu Luo; Dola Das; Ajay Singh; Neena Singh
Journal:  Mol Brain       Date:  2010-04-29       Impact factor: 4.041

6.  Phenotypic characterization of cells participating in transport of prion protein aggregates across the intestinal mucosa of sheep.

Authors:  Caroline Piercey Åkesson; Charles McL Press; Michael A Tranulis; Martin Jeffrey; Mona Aleksandersen; Thor Landsverk; Arild Espenes
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

7.  Blocking of FcR suppresses the intestinal invasion of scrapie agents.

Authors:  Ryuta Uraki; Akikazu Sakudo; Kosuke Michibata; Yasuhisa Ano; Jyuri Kono; Masayoshi Yukawa; Takashi Onodera
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

8.  Exosome-producing follicle associated epithelium is not involved in uptake of PrPd from the gut of sheep (Ovis aries): an ultrastructural study.

Authors:  Caroline Piercey Åkesson; Gillian McGovern; Mark P Dagleish; Arild Espenes; Charles McL Press; Thor Landsverk; Martin Jeffrey
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

9.  Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?

Authors:  Kedar N Prasad; Stephen C Bondy
Journal:  Curr Aging Sci       Date:  2019

10.  Human prion diseases in the United States.

Authors:  Robert C Holman; Ermias D Belay; Krista Y Christensen; Ryan A Maddox; Arialdi M Minino; Arianne M Folkema; Dana L Haberling; Teresa A Hammett; Kenneth D Kochanek; James J Sejvar; Lawrence B Schonberger
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.